GTG.AX: Summary for GENE TECH FPO- Yahoo!7 Finance

All Ordinaries

1.11%

Streaming

Ticker Tape: On

Genetic Technologies Limited (GTG.AX)

-ASX

0.10 0.00(0.00%) 11:07

Add to Portfolio

Prev Close:	0.10
Open:	0.10
Bid:	0.08
Ask:	0.10
1y Target Est:	N/A
Beta:	N/A
Next Earnings Date:	N/A

Day's Range:	0.10 - 0.10
52wk Range:	0.06 - 0.15
Volume:	100,000
Avg Vol (3m):	319,050
Market Cap:	46.15M
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A)

People viewing GTG.AX also viewed: GENE

Quotes delayed, except where indicated otherwise. Currency in AUD.

Headlines

Licensing Updateat Reuters(Tue 19 Mar)
Genetic Technologies Provides U.S. Patent Re-Examination UpdateMarketwired(Fri 15 Mar)
US patent re-examination updateat Reuters(Fri 15 Mar)
Myriad Genetics Win on Gene Patent Ownership Is Appealedat Bloomberg(Mon 4 Mar)
Genetic Technologies Announces Financial Results for Half-Year Ended 31 December 2012Marketwired(Fri 22 Feb)
Australian court supports patents on human genesat Reuters(Fri 15 Feb)
Myriad Genetics Wins Australia Bid to Patent Human Genesat Bloomberg(Fri 15 Feb)
Genetic Technologies Appoints Chief Executive Officer and Non-Executive DirectorMarketwired(Mon 10 Dec)
Appointment of permanent CEO and Non-Executive Directorat Reuters(Mon 10 Dec)
Genetic Technologies Provides Update on Board and Management ChangesMarketwired(Thu 29 Nov)

» More Headlines for GTG.AX

Press Releases

Genetic Technologies Executes Agreement With Further Nationwide Provider Network for BREVAGen(TM)Marketwired(Wed 19 Jun)
Genetic Technologies Provides U.S. Gene Patenting UpdateMarketwired(Mon 17 Jun)
PropThink: Genetic Technologies' Wednesday Gains Unsustainable, Declining Without Momentumat Reuters(Sat 1 Sep)

» More Press Releases for GTG.AX

customise chart

Comparison

Symbol	% Chg	Mkt Cap
GTG.AX	0.00%	46.15M
TMO	1.73%	30.40B
WYETH.NS	0.57%	17.85B
WYETH.BO	0.85%	17.84B
A	2.86%	14.99B

» More Competitors

Key Statistics

Forward P/E (1 yr):	N/A
P/S (ttm):	13.03
Ex-Dividend Date:	N/A

» More Key Statistics

Analysts

Annual EPS Est (Jun-13) :	N/A
Quarterly EPS Est (0-00-31) :	N/A
Mean Recommendation*:	N/A
PEG Ratio (5 yr expected):	N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genetic Technologies Limited provides genetic testing services. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine cancer; neurogenetic diagnostic assays; and ... View More

Company Profile | Industry

Toolbox

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo!7 nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo!7 site, you agree not to redistribute the information found therein.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. Real-Time quotes provided by BATS Exchange. US Financials data provided by Edgar Online and all other Financials provided by Capital IQ.

Yahoo! Finance

Search for share prices

More On GTG.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials